{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:02:46Z","timestamp":1791212566632,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0973-1482.146093","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T02:43:41Z","timestamp":1460429021000},"page":"182","source":"Crossref","is-referenced-by-count":4,"title":["Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic\/severe combined immunodeficiency mice"],"prefix":"10.4103","volume":"12","author":[{"given":"Yongzhan","family":"Zhen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsu","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.146093-1","first-page":"763","volume-title":"Understanding the hypoxic niche of multiple myeloma: Therapeutic implications and contributions of mouse models","author":"Hu","year":"2012","journal-title":"Dis Model Mech"},{"key":"key-10.4103\/0973-1482.146093-2","first-page":"429","volume-title":"Relapse after allogeneic stem cell transplantation","author":"Barrett","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"key-10.4103\/0973-1482.146093-3","first-page":"224","volume-title":"Lidamycin regulates p53 expression by repressing Oct4 transcription","author":"Zhen","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/0973-1482.146093-4","doi-asserted-by":"crossref","unstructured":"Chen Y, Yu D, Zhang C, Shang B, He H, et al. Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3\u00df\/\u00df-catenin pathway. Mol Carcinog 2013.","DOI":"10.1002\/mc.22069"},{"key":"key-10.4103\/0973-1482.146093-5","first-page":"645","volume-title":"Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro","author":"Liu","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"key-10.4103\/0973-1482.146093-6","first-page":"4","volume-title":"Lidamycin induces neural differentiation of mouse embryonic carcinoma cells through down-regulation of transcription factor Oct4","author":"Zhen","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/0973-1482.146093-7","first-page":"41","volume-title":"Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells","author":"Liu","year":"2009","journal-title":"Anticancer Drugs"},{"key":"key-10.4103\/0973-1482.146093-8","first-page":"4","volume-title":"Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase","author":"Zhen","year":"2009","journal-title":"Int J Hematol"},{"key":"key-10.4103\/0973-1482.146093-9","first-page":"1146","volume-title":"Chemosensitivity of mdr1 gene overexpressed multidrug resistant cancer cells to lidamycin","author":"Shi","year":"2006","journal-title":"Yao Xue Xue Bao"},{"key":"key-10.4103\/0973-1482.146093-10","first-page":"1462","volume-title":"Inhibitory effects of the immunoconjugate composed of anti-type IV collagenase antibody Fab' fragment and lidamycin on tumor invasion and metastasis","author":"Feng","year":"2011","journal-title":"Yao Xue Xue Bao"},{"key":"key-10.4103\/0973-1482.146093-11","first-page":"8","volume-title":"Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma","author":"Zhang","year":"2013","journal-title":"Oncol Lett"},{"key":"key-10.4103\/0973-1482.146093-12","first-page":"609","volume-title":"Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells","author":"Zhen","year":"2013","journal-title":"Anticancer Drugs"},{"key":"key-10.4103\/0973-1482.146093-13","first-page":"1025","volume-title":"Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice","author":"Zhen","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"key-10.4103\/0973-1482.146093-14","first-page":"372","volume-title":"Clinical experience with thalidomide and lenalidomide in multiple myeloma","author":"Moehler","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"key-10.4103\/0973-1482.146093-15","first-page":"438","volume-title":"Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma","author":"Mateos","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0973-1482.146093-16","first-page":"4","volume-title":"Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma","author":"Rabin","year":"2012","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0973-1482.146093-17","first-page":"167","volume-title":"Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma","author":"Abidi","year":"2012","journal-title":"J Chemother"},{"key":"key-10.4103\/0973-1482.146093-18","first-page":"1925","volume-title":"Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma","author":"Arnulf","year":"2012","journal-title":"Haematologica"},{"key":"key-10.4103\/0973-1482.146093-19","first-page":"947","volume-title":"Proteasome inhibitors in multiple myeloma: 10 years later","author":"Moreau","year":"2012","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.146093-20","first-page":"718","volume-title":"Halofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents","author":"Leiba","year":"2012","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0973-1482.146093-21","first-page":"273","volume-title":"Naltrindole inhibits human multiple myeloma cell proliferation in vitro and in a murine xenograft model in vivo","author":"Mundra","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0973-1482.146093-22","first-page":"2074","volume-title":"Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function","author":"Tai","year":"2012","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.146093-23","first-page":"2","volume-title":"More than cell death: Caspases and caspase inhibitors on the move","author":"Dotto","year":"2004","journal-title":"Dev Cell"},{"key":"key-10.4103\/0973-1482.146093-24","first-page":"130","volume-title":"CGRP inhibits norepinephrine induced apoptosis with restoration of Bcl-2\/Bax in cultured cardiomyocytes of rat","author":"Ma","year":"2013","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0973-1482.146093-25","first-page":"2","volume-title":"Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2\/Bax balance","author":"Zeng","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"key-10.4103\/0973-1482.146093-26","first-page":"19273","volume-title":"Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer","author":"Kaneko","year":"2007","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0973-1482.146093-27","first-page":"201","volume-title":"Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway","author":"Premkumar","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/0973-1482.146093-28","first-page":"e59639","volume-title":"Apoptosis through Bcl-2\/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy","author":"Fai\u00e3o-Flores","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:28:33Z","timestamp":1786714113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-1482.146093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["146093"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.146093","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}